Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 467


SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis.

Uygur B, Wu WS.

Mol Cancer. 2011 Nov 10;10:139. doi: 10.1186/1476-4598-10-139.


Slug inhibits proliferation of human prostate cancer cells via downregulation of cyclin D1 expression.

Liu J, Uygur B, Zhang Z, Shao L, Romero D, Vary C, Ding Q, Wu WS.

Prostate. 2010 Dec 1;70(16):1768-77. doi: 10.1002/pros.21213.


Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.

Ding G, Fang J, Tong S, Qu L, Jiang H, Ding Q, Liu J.

Prostate. 2015 Jun 15;75(9):957-68. doi: 10.1002/pros.22978.


SLUG is a direct transcriptional repressor of PTEN tumor suppressor.

Uygur B, Abramo K, Leikina E, Vary C, Liaw L, Wu WS.

Prostate. 2015 Jun 15;75(9):907-16. doi: 10.1002/pros.22974.


Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.

Hsiao JJ, Ng BH, Smits MM, Wang J, Jasavala RJ, Martinez HD, Lee J, Alston JJ, Misonou H, Trimmer JS, Wright ME.

BMC Cancer. 2015 Mar 31;15:204. doi: 10.1186/s12885-015-1201-5.


CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion.

Singh S, Singh UP, Grizzle WE, Lillard JW Jr.

Lab Invest. 2004 Dec;84(12):1666-76.


PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling.

Conley-LaComb MK, Saliganan A, Kandagatla P, Chen YQ, Cher ML, Chinni SR.

Mol Cancer. 2013 Jul 31;12(1):85. doi: 10.1186/1476-4598-12-85.


The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.

Arya M, Patel HR, McGurk C, Tatoud R, Klocker H, Masters J, Williamson M.

J Exp Ther Oncol. 2004 Dec;4(4):291-303.


Peroxisome proliferator‑activated receptor γ agonist rosiglitazone inhibits migration and invasion of prostate cancer cells through inhibition of the CXCR4/CXCL12 axis.

Qin L, Gong C, Chen AM, Guo FJ, Xu F, Ren Y, Liao H.

Mol Med Rep. 2014 Aug;10(2):695-700. doi: 10.3892/mmr.2014.2232.


Stromal-derived factor-1α/CXCL12-CXCR4 chemotactic pathway promotes perineural invasion in pancreatic cancer.

Xu Q, Wang Z, Chen X, Duan W, Lei J, Zong L, Li X, Sheng L, Ma J, Han L, Li W, Zhang L, Guo K, Ma Z, Wu Z, Wu E, Ma Q.

Oncotarget. 2015 Mar 10;6(7):4717-32.


Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitro.

Frigo DE, Sherk AB, Wittmann BM, Norris JD, Wang Q, Joseph JD, Toner AP, Brown M, McDonnell DP.

Mol Endocrinol. 2009 Sep;23(9):1385-96. doi: 10.1210/me.2009-0010.


[Effect of chemokine CXCL12 and its receptor CXCR4 on proliferation, migration and invasion of epithelial ovarian cancer cells].

Jiang YP, Wu XH, Xing HY, DU XY.

Zhonghua Fu Chan Ke Za Zhi. 2007 Jun;42(6):403-7. Chinese.


CXCR4-mediated Stat3 activation is essential for CXCL12-induced cell invasion in bladder cancer.

Shen HB, Gu ZQ, Jian K, Qi J.

Tumour Biol. 2013 Jun;34(3):1839-45. doi: 10.1007/s13277-013-0725-z.


CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells.

Hu W, Zhen X, Xiong B, Wang B, Zhang W, Zhou W.

Cancer Sci. 2008 Jul;99(7):1362-9. doi: 10.1111/j.1349-7006.2008.00833.x. Erratum in: Cancer Sci. 2008 Dec;99(12):2548.


Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/β-catenin pathway in human colon cancer cells.

Song ZY, Gao ZH, Chu JH, Han XZ, Qu XJ.

Biomed Pharmacother. 2015 Apr;71:46-52. doi: 10.1016/j.biopha.2015.01.020.


CXCL12-CXCR4 promotes proliferation and invasion of pancreatic cancer cells.

Shen B, Zheng MQ, Lu JW, Jiang Q, Wang TH, Huang XE.

Asian Pac J Cancer Prev. 2013;14(9):5403-8.


Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model.

Shanmugam MK, Manu KA, Ong TH, Ramachandran L, Surana R, Bist P, Lim LH, Kumar AP, Hui KM, Sethi G.

Int J Cancer. 2011 Oct 1;129(7):1552-63. doi: 10.1002/ijc.26120.


Chemokine CXCL12 and its receptor CXCR4 expression are associated with perineural invasion of prostate cancer.

Zhang S, Qi L, Li M, Zhang D, Xu S, Wang N, Sun B.

J Exp Clin Cancer Res. 2008 Nov 4;27:62. doi: 10.1186/1756-9966-27-62.

Items per page

Supplemental Content

Support Center